Steve Riley

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study

Thibaud Damy, Pablo García‐Pavía, Mazen Hanna et al. · European Journal of Heart Failure · 2020 · 202 citations · Full text

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

Wonkyung Byon, P Chan, MA Tortorici et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 181 citations · Full text

Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase

Börje Darpö, Charles Benson, Corina Dota et al. · Clinical Pharmacology & Therapeutics · 2015 · 176 citations · Full text

Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward

Börje Darpö, Christine Garnett, Charles Benson et al. · American Heart Journal · 2014 · 61 citations

Heart Failure, Cardiovascular Translational Research, Cardiovascular Disease +12